Please assess the completion status of the following clinical trial:

Trial Title: Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \>= 1 year of infertility~* \>21 and \<40 years old~* Normal HSG~* Normal Semen analysis (Count \>= 20 million/ motility \> 50%/ Kruger morph \> 14%.~* Absent menses~* Willingness to sign informed consent for study randomization~* Willingness to participate in 3 months of treatment.~Exclusion Criteria:~* Abnormal semen analysis~* Abnormal HSG~* Medical condition that would contraindicate pregnancy, ovulation induction or general anesthesia~* Family history of significant genetic disease, or factor V leiden thrombophilia~* Inability to present for monitoring visits~* Inability to follow medication instruction~* Desire to undergo other fertility treatments before completing three months of this trial

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: 39 Years
- Healthy Volunteers: t

Study Arms:
- DHEA active treatment (Type: EXPERIMENTAL): Dehydroepiandrosterone 25 mg tid po
- DHEA Placebo (Type: PLACEBO_COMPARATOR): Blinded placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).